http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040062602-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 |
filingDate | 2002-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20040062602-A |
titleOfInvention | Dermopharmaceutically and cosmetically active oligopeptides |
abstract | The present invention provides oligopeptides and derivatives thereof, peptide analogs and derivatives thereof, and salts of these pharmaceutically acceptable compounds corresponding to general formula (I) below; And a dermatological and / or cosmetically active composition containing at least one of the compounds of formula (I):n n n [Formula (I)]n n n n n n n n Wheren n n R 1 represents H, —C (O) —R 7 , —SO 2 —R 7 , —C (O) —OR 7 or —C (O) —N (R 7 ) 2 ;n n n R 2 , independently of one another, represent H or — (C 1 -C 4 ) -alkyl;n n n R 3 and R 6 independently of one another represent — (CH 2 ) q —N (R 1 ) R 8 ;n n n R 4 and R 5 independently of one another, represent —CH 2 —OR 2 , —CH (CH 3 ) OR 8 or —CH 2 —CH 2 —OR 8 ;n n n R 7 is hydrogen; Optionally substituted (C 1 -C 19 ) -alkyl; Optionally substituted (C 1 -C 19 ) -alkenyl; Or phenyl- (C 1 -C 4 ) -alkyl, wherein the phenyl radical is optionally substituted in the para position;n n n R 8 is H,-(C 1 -C 4 ) -alkyl, -C (O) -R 7 , -C (O) -OR 7 , -C (O) -N (R 7 ) 2 or -SO 2 -R 7 ;n n n X represents oxygen (-O-) or NH-;n n n XR 7 when X is O represents an ester of α-tocopherol, tocotrienol or retinol, or carboxylic acid (R 7 = H);n n n m, n, p represent 0 or 1, independently of each other;n n n Q in R 3 and R 6 independently of each other represent an integer of 1 to 4;n n n However, the case where R 4 = -CH (CH 3 ) -OH and R 5 = -CH (CH 3 ) -OH and R 6 =-(CH 2 ) 4 -NH 2 does not occur. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101518077-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758485-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905637-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576034-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486409-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140043727-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285941-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311496-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724299-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532019-B2 |
priorityDate | 2001-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 165.